Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...
Amgen (AMGN) announced new data from the Phase 3, registrational MINT trial evaluating the efficacy and safety of Uplinza in adults living with ...
We recently compiled a list of the 11 Best Undervalued Stocks to Invest in Now. In this article, we are going to take a look ...
Shares of Amgen Inc. AMGN slipped 1.16% to $291.16 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,114.63 and ...
BofA raised the firm’s price target on Amgen (AMGN) to $275 from $256 and keeps an Underperform rating on the shares. Q4 results were slightly below consensus on total revenue, but above on EPS ...
In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other pharmaceutical stocks. Almost no other industry goes as far as the phrase "defensive" as the ...
Drugmaker Amgen to invest $200 million in India site, CEO says U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...
In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best performing Dow stocks so far in 2025. The Dow is a renowned and significant stock market ...
Amgen Inc currently pays a quarterly dividend of $9.52 per year for a yield of 3.05%. Amgen Inc last traded ex-dividend on Feb 14 and the next ex-dividend date is scheduled for May 16. Amgen's ...
In recent trading, shares of Amgen Inc (Symbol: AMGN) have crossed above the average analyst 12-month target price of $317.58, changing hands for $317.82/share. When a stock reaches the target an ...
The Dow Jones Industrial Average is climbing Wednesday afternoon with shares of Amgen and NVIDIA Corp. seeing positive growth for the index. Supported by world-class markets data from Dow Jones ...